Christine E. Archbold - 30 Jan 2026 Form 4 Insider Report for AdaptHealth Corp. (AHCO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Feb 2026, 20:15:19 UTC
Prior SEC filing
04 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard Rew, as attorney-in-fact for Christine Archbold

Key filing fact

Christine E. Archbold filed Form 4 for AdaptHealth Corp. (AHCO) on 03 Feb 2026.

Key facts

  • This page summarizes Christine E. Archbold's Form 4 filing for AdaptHealth Corp. (AHCO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Feb 2026, 20:15.

Change

  • Previous filing in this sequence was filed on 04 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001802571 Primary reporting owner

Archbold Christine E.

Relationship
Chief Accounting Officer
Address
C/O ADAPTHEALTH LLC, 555 EAST NORTH LANE, SUITE 5075, CONSHOHOCKEN
Signature
/s/ Richard Rew, as attorney-in-fact for Christine Archbold
Signature date
03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AHCO transaction

Common Stock

Award

Transaction value
$0
Shares
+32,213
Change %
+43%
Price
$0.000000
Shares after
107,198
Date
30 Jan 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares represent restricted stock units and will be settled in common stock upon vesting.

SEC remarks

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .